5,241 reports of this reaction
8.3% of all METHYLPHENIDATE reports
#3 most reported adverse reaction
PRODUCT QUALITY ISSUE is the #3 most commonly reported adverse reaction for METHYLPHENIDATE, manufactured by Noven Therapeutics, LLC. There are 5,241 FDA adverse event reports linking METHYLPHENIDATE to PRODUCT QUALITY ISSUE. This represents approximately 8.3% of all 63,290 adverse event reports for this drug.
Patients taking METHYLPHENIDATE who experience product quality issue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PRODUCT QUALITY ISSUE is moderately reported among METHYLPHENIDATE users, representing a notable but not dominant share of adverse events.
In addition to product quality issue, the following adverse reactions have been reported for METHYLPHENIDATE:
The following drugs have also been linked to product quality issue in FDA adverse event reports:
PRODUCT QUALITY ISSUE has been reported as an adverse event in 5,241 FDA reports for METHYLPHENIDATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
PRODUCT QUALITY ISSUE accounts for approximately 8.3% of all adverse event reports for METHYLPHENIDATE, making it one of the most commonly reported side effect.
If you experience product quality issue while taking METHYLPHENIDATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.